Propensity‐score matching with competing risks in survival analysis
Propensity‐score matching is a popular analytic method to remove the effects of confounding due to measured baseline covariates when using observational data to estimate the effects of treatment. Time‐to‐event outcomes are common in medical research. Competing risks are outcomes whose occurrence pre...
Gespeichert in:
Veröffentlicht in: | Statistics in medicine 2019-02, Vol.38 (5), p.751-777 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 777 |
---|---|
container_issue | 5 |
container_start_page | 751 |
container_title | Statistics in medicine |
container_volume | 38 |
creator | Austin, Peter C. Fine, Jason P. |
description | Propensity‐score matching is a popular analytic method to remove the effects of confounding due to measured baseline covariates when using observational data to estimate the effects of treatment. Time‐to‐event outcomes are common in medical research. Competing risks are outcomes whose occurrence precludes the occurrence of the primary time‐to‐event outcome of interest. All non‐fatal outcomes and all cause‐specific mortality outcomes are potentially subject to competing risks. There is a paucity of guidance on the conduct of propensity‐score matching in the presence of competing risks. We describe how both relative and absolute measures of treatment effect can be obtained when using propensity‐score matching with competing risks data. Estimates of the relative effect of treatment can be obtained by using cause‐specific hazard models in the matched sample. Estimates of absolute treatment effects can be obtained by comparing cumulative incidence functions (CIFs) between matched treated and matched control subjects. We conducted a series of Monte Carlo simulations to compare the empirical type I error rate of different statistical methods for testing the equality of CIFs estimated in the matched sample. We also examined the performance of different methods to estimate the marginal subdistribution hazard ratio. We recommend that a marginal subdistribution hazard model that accounts for the within‐pair clustering of outcomes be used to test the equality of CIFs and to estimate subdistribution hazard ratios. We illustrate the described methods by using data on patients discharged from hospital with acute myocardial infarction to estimate the effect of discharge prescribing of statins on cardiovascular death. |
doi_str_mv | 10.1002/sim.8008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6900780</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179177442</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4388-e4193548c00f170d377b2ced22192cb0bbd512006adccaab9cdedbde2e45cfd33</originalsourceid><addsrcrecordid>eNp1kM1KAzEQx4MotlbBJ5AFL162TrIf2b0IUqoWKgrqOWSTbJu6Xya7LXvzEXxGn8StrUUPnoZhfvxm5o_QKYYhBiCXVufDCCDaQ30MMXWBBNE-6gOh1A0pDnroyNoFAMYBoYeo54HnUz_EfTR-NGWlCqvr9vP9w4rSKCfntZjrYuasdD13RJlXql63RttX6-jCsY1Z6iXPHF7wrLXaHqODlGdWnWzrAL3cjJ9Hd-704XYyup66wveiyFU-jr3AjwRAiilIj9KECCUJwTERCSSJDDABCLkUgvMkFlLJRCqi_ECk0vMG6GrjrZokV1KoojY8Y5XROTctK7lmfyeFnrNZuWRhDEAj6ATnW4Ep3xpla7YoG9N9YRnBNMaU-j7pqIsNJUxprVHpbgMGtg6cdYGzdeAdevb7oh34k3AHuBtgpTPV_itiT5P7b-EXWsaNcQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179177442</pqid></control><display><type>article</type><title>Propensity‐score matching with competing risks in survival analysis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Austin, Peter C. ; Fine, Jason P.</creator><creatorcontrib>Austin, Peter C. ; Fine, Jason P.</creatorcontrib><description>Propensity‐score matching is a popular analytic method to remove the effects of confounding due to measured baseline covariates when using observational data to estimate the effects of treatment. Time‐to‐event outcomes are common in medical research. Competing risks are outcomes whose occurrence precludes the occurrence of the primary time‐to‐event outcome of interest. All non‐fatal outcomes and all cause‐specific mortality outcomes are potentially subject to competing risks. There is a paucity of guidance on the conduct of propensity‐score matching in the presence of competing risks. We describe how both relative and absolute measures of treatment effect can be obtained when using propensity‐score matching with competing risks data. Estimates of the relative effect of treatment can be obtained by using cause‐specific hazard models in the matched sample. Estimates of absolute treatment effects can be obtained by comparing cumulative incidence functions (CIFs) between matched treated and matched control subjects. We conducted a series of Monte Carlo simulations to compare the empirical type I error rate of different statistical methods for testing the equality of CIFs estimated in the matched sample. We also examined the performance of different methods to estimate the marginal subdistribution hazard ratio. We recommend that a marginal subdistribution hazard model that accounts for the within‐pair clustering of outcomes be used to test the equality of CIFs and to estimate subdistribution hazard ratios. We illustrate the described methods by using data on patients discharged from hospital with acute myocardial infarction to estimate the effect of discharge prescribing of statins on cardiovascular death.</description><identifier>ISSN: 0277-6715</identifier><identifier>EISSN: 1097-0258</identifier><identifier>DOI: 10.1002/sim.8008</identifier><identifier>PMID: 30347461</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>competing risk ; Computer Simulation ; cumulative incidence function ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; matching ; Monte Carlo Method ; Monte Carlo simulations ; Myocardial Infarction - drug therapy ; Myocardial Infarction - mortality ; Patient Discharge - statistics & numerical data ; Propensity Score ; propensity score matching ; Research Design ; Risk ; Survival Analysis</subject><ispartof>Statistics in medicine, 2019-02, Vol.38 (5), p.751-777</ispartof><rights>2018 The Authors. Published by John Wiley & Sons Ltd.</rights><rights>2018 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd.</rights><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4388-e4193548c00f170d377b2ced22192cb0bbd512006adccaab9cdedbde2e45cfd33</citedby><cites>FETCH-LOGICAL-c4388-e4193548c00f170d377b2ced22192cb0bbd512006adccaab9cdedbde2e45cfd33</cites><orcidid>0000-0003-3337-233X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fsim.8008$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fsim.8008$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30347461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Austin, Peter C.</creatorcontrib><creatorcontrib>Fine, Jason P.</creatorcontrib><title>Propensity‐score matching with competing risks in survival analysis</title><title>Statistics in medicine</title><addtitle>Stat Med</addtitle><description>Propensity‐score matching is a popular analytic method to remove the effects of confounding due to measured baseline covariates when using observational data to estimate the effects of treatment. Time‐to‐event outcomes are common in medical research. Competing risks are outcomes whose occurrence precludes the occurrence of the primary time‐to‐event outcome of interest. All non‐fatal outcomes and all cause‐specific mortality outcomes are potentially subject to competing risks. There is a paucity of guidance on the conduct of propensity‐score matching in the presence of competing risks. We describe how both relative and absolute measures of treatment effect can be obtained when using propensity‐score matching with competing risks data. Estimates of the relative effect of treatment can be obtained by using cause‐specific hazard models in the matched sample. Estimates of absolute treatment effects can be obtained by comparing cumulative incidence functions (CIFs) between matched treated and matched control subjects. We conducted a series of Monte Carlo simulations to compare the empirical type I error rate of different statistical methods for testing the equality of CIFs estimated in the matched sample. We also examined the performance of different methods to estimate the marginal subdistribution hazard ratio. We recommend that a marginal subdistribution hazard model that accounts for the within‐pair clustering of outcomes be used to test the equality of CIFs and to estimate subdistribution hazard ratios. We illustrate the described methods by using data on patients discharged from hospital with acute myocardial infarction to estimate the effect of discharge prescribing of statins on cardiovascular death.</description><subject>competing risk</subject><subject>Computer Simulation</subject><subject>cumulative incidence function</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>matching</subject><subject>Monte Carlo Method</subject><subject>Monte Carlo simulations</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - mortality</subject><subject>Patient Discharge - statistics & numerical data</subject><subject>Propensity Score</subject><subject>propensity score matching</subject><subject>Research Design</subject><subject>Risk</subject><subject>Survival Analysis</subject><issn>0277-6715</issn><issn>1097-0258</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kM1KAzEQx4MotlbBJ5AFL162TrIf2b0IUqoWKgrqOWSTbJu6Xya7LXvzEXxGn8StrUUPnoZhfvxm5o_QKYYhBiCXVufDCCDaQ30MMXWBBNE-6gOh1A0pDnroyNoFAMYBoYeo54HnUz_EfTR-NGWlCqvr9vP9w4rSKCfntZjrYuasdD13RJlXql63RttX6-jCsY1Z6iXPHF7wrLXaHqODlGdWnWzrAL3cjJ9Hd-704XYyup66wveiyFU-jr3AjwRAiilIj9KECCUJwTERCSSJDDABCLkUgvMkFlLJRCqi_ECk0vMG6GrjrZokV1KoojY8Y5XROTctK7lmfyeFnrNZuWRhDEAj6ATnW4Ep3xpla7YoG9N9YRnBNMaU-j7pqIsNJUxprVHpbgMGtg6cdYGzdeAdevb7oh34k3AHuBtgpTPV_itiT5P7b-EXWsaNcQ</recordid><startdate>20190228</startdate><enddate>20190228</enddate><creator>Austin, Peter C.</creator><creator>Fine, Jason P.</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3337-233X</orcidid></search><sort><creationdate>20190228</creationdate><title>Propensity‐score matching with competing risks in survival analysis</title><author>Austin, Peter C. ; Fine, Jason P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4388-e4193548c00f170d377b2ced22192cb0bbd512006adccaab9cdedbde2e45cfd33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>competing risk</topic><topic>Computer Simulation</topic><topic>cumulative incidence function</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>matching</topic><topic>Monte Carlo Method</topic><topic>Monte Carlo simulations</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - mortality</topic><topic>Patient Discharge - statistics & numerical data</topic><topic>Propensity Score</topic><topic>propensity score matching</topic><topic>Research Design</topic><topic>Risk</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Austin, Peter C.</creatorcontrib><creatorcontrib>Fine, Jason P.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Statistics in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Austin, Peter C.</au><au>Fine, Jason P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Propensity‐score matching with competing risks in survival analysis</atitle><jtitle>Statistics in medicine</jtitle><addtitle>Stat Med</addtitle><date>2019-02-28</date><risdate>2019</risdate><volume>38</volume><issue>5</issue><spage>751</spage><epage>777</epage><pages>751-777</pages><issn>0277-6715</issn><eissn>1097-0258</eissn><abstract>Propensity‐score matching is a popular analytic method to remove the effects of confounding due to measured baseline covariates when using observational data to estimate the effects of treatment. Time‐to‐event outcomes are common in medical research. Competing risks are outcomes whose occurrence precludes the occurrence of the primary time‐to‐event outcome of interest. All non‐fatal outcomes and all cause‐specific mortality outcomes are potentially subject to competing risks. There is a paucity of guidance on the conduct of propensity‐score matching in the presence of competing risks. We describe how both relative and absolute measures of treatment effect can be obtained when using propensity‐score matching with competing risks data. Estimates of the relative effect of treatment can be obtained by using cause‐specific hazard models in the matched sample. Estimates of absolute treatment effects can be obtained by comparing cumulative incidence functions (CIFs) between matched treated and matched control subjects. We conducted a series of Monte Carlo simulations to compare the empirical type I error rate of different statistical methods for testing the equality of CIFs estimated in the matched sample. We also examined the performance of different methods to estimate the marginal subdistribution hazard ratio. We recommend that a marginal subdistribution hazard model that accounts for the within‐pair clustering of outcomes be used to test the equality of CIFs and to estimate subdistribution hazard ratios. We illustrate the described methods by using data on patients discharged from hospital with acute myocardial infarction to estimate the effect of discharge prescribing of statins on cardiovascular death.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30347461</pmid><doi>10.1002/sim.8008</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3337-233X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0277-6715 |
ispartof | Statistics in medicine, 2019-02, Vol.38 (5), p.751-777 |
issn | 0277-6715 1097-0258 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6900780 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | competing risk Computer Simulation cumulative incidence function Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use matching Monte Carlo Method Monte Carlo simulations Myocardial Infarction - drug therapy Myocardial Infarction - mortality Patient Discharge - statistics & numerical data Propensity Score propensity score matching Research Design Risk Survival Analysis |
title | Propensity‐score matching with competing risks in survival analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T06%3A46%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Propensity%E2%80%90score%20matching%20with%20competing%20risks%20in%20survival%20analysis&rft.jtitle=Statistics%20in%20medicine&rft.au=Austin,%20Peter%20C.&rft.date=2019-02-28&rft.volume=38&rft.issue=5&rft.spage=751&rft.epage=777&rft.pages=751-777&rft.issn=0277-6715&rft.eissn=1097-0258&rft_id=info:doi/10.1002/sim.8008&rft_dat=%3Cproquest_pubme%3E2179177442%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179177442&rft_id=info:pmid/30347461&rfr_iscdi=true |